Immix Biopharma Inc
General ticker "IMMX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $63.0M
Immix Biopharma Inc does not follow the US Stock Market performance with the rate: -28.6%.
Estimated limits based on current volatility of 8.3%: low 1.99$, high 2.30$
Factors to consider:
- Current price 36.3% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.42$, 8.61$]
- 2024-12-30 to 2025-12-30 estimated range: [2.44$, 6.50$]
Financial Metrics affecting the IMMX estimates:
- Negative: Non-GAAP EPS, $ of -0.89 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -10.46 <= 2.35
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term IMMX quotes
Long-term IMMX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $1.35MM | $8.22MM | $16.14MM |
| Operating Income | $-1.35MM | $-8.22MM | $-16.14MM |
| Non-Operating Income | $-23.03MM | $-0.00MM | $0.57MM |
| Interest Expense | $0.18MM | $0.00MM | $0.00MM |
| R&D Expense | $0.13MM | $4.20MM | $8.74MM |
| Income(Loss) | $-24.38MM | $-8.22MM | $-15.57MM |
| Taxes | $0.01MM | $0.01MM | $-0.14MM |
| Profit(Loss) | $-24.38MM | $-8.23MM | $-15.43MM |
| Stockholders Equity | $17.99MM | $13.16MM | $16.41MM |
| Assets | $18.19MM | $14.91MM | $19.93MM |
| Operating Cash Flow | $-1.59MM | $-7.41MM | $-11.37MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.05MM |
| Investing Cash Flow | $-0.01MM | $-0.03MM | $-0.05MM |
| Financing Cash Flow | $18.85MM | $3.23MM | $15.46MM |
| Earnings Per Share* | $-1.84 | $-0.62 | $-0.89 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.